GBT Chart
- 52-Week Range: $22.94 - $41.67
- Market Capitalization: $1.72B
- Short Percentage: 0%
- Target Price: $59.63
- Shares Outstanding: 65.10M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GBT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- GBT Launches Inaugural Environmental, Social and Governance (ESG) ReportGlobeNewsWire | April 28th
- GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease DayGlobeNewsWire | March 24th
- Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 23rd
- GBT to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 23, 2022GlobeNewsWire | February 16th
- Global Blood Therapeutics' Oxbryta Scores European Approval For Sickle Cell DiseaseBenzinga | February 16th
Company Info
Website: https://www.gbt.com
Address: 181 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 457
Address: 181 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 457
$GBT Holding
$GBT looking ready to breakout soon.
$GBT make it rain
let’s see some green
$GBT nice
$GBT I’m not saying you guys are a bunch of whores
but I’m also not not saying it
$GBT Overpower the algos!
$GBT futes cooperating!
$GBT never selling
$GBT Reinvest your dividends
$GBT buying this dip